CTIM-21. NRG-BN010: A SAFETY RUN-IN AND PHASE II STUDY EVALUATING THE COMBINATION OF TOCILIZUMAB, ATEZOLIZUMAB, AND FRACTIONATED STEREOTACTIC RADIOTHERAPY IN RECURRENT GLIOBLASTOMA–TRIAL IN PROGRESS
Publication Date
2022
Content Type
Article
Publisher's Site:
Citation
Neuro-Oncology (2022) 24(Supplement_7):vii64-vii64